Literature DB >> 32205321

Covid-19: six million doses of hydroxychloroquine donated to US despite lack of evidence.

Elisabeth Mahase1.   

Abstract

Entities:  

Year:  2020        PMID： 32205321     DOI： 10.1136/bmj.m1166

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  17 in total

1.  Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit.

Authors:  Francis Bessière; Hugo Roccia; Antoine Delinière; Rome Charrière; Philippe Chevalier; Laurent Argaud; Martin Cour
Journal:  JAMA Cardiol       Date:  2020-05-01       Impact factor: 14.676

2.  Case Report: Hepatotoxicity Associated with the Use of Hydroxychloroquine in a Patient with COVID-19.

Authors:  Melissa Barreto Falcão; Luciano Pamplona de Góes Cavalcanti; Nivaldo Menezes Filgueiras Filho; Carlos Alexandre Antunes de Brito
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

3.  Impact of gamma-irradiation on the degradation and mineralization of hydroxychloroquine aqueous solutions.

Authors:  A Zaouak; S Jebali; H Chouchane; H Jelassi
Journal:  Int J Environ Sci Technol (Tehran)       Date:  2022-07-07       Impact factor: 3.519

4.  Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit.

Authors:  Francis Bessière; Hugo Roccia; Antoine Delinière; Rome Charrière; Philippe Chevalier; Laurent Argaud; Martin Cour
Journal:  JAMA Cardiol       Date:  2020-09-01       Impact factor: 14.676

5.  Quantity does not equal quality: Scientific principles cannot be sacrificed.

Authors:  Piotr Rzymski; Michał Nowicki; Gerard E Mullin; Ajith Abraham; Eduardo Rodríguez-Román; Moritz B Petzold; Antonia Bendau; Kamal Kant Sahu; Amber Ather; Anne-Frédérique Naviaux; Pascal Janne; Maximilien Gourdin; Joris R Delanghe; Hans D Ochs; James E Talmadge; Manish Garg; Michael R Hamblin; Nima Rezaei
Journal:  Int Immunopharmacol       Date:  2020-06-22       Impact factor: 4.932

6.  Use of antimalarial drugs in the treatment of COVID-19: A window of opportunity?

Authors:  Isabel Lasheras; Javier Santabárbara
Journal:  Med Clin (Barc)       Date:  2020-04-22       Impact factor: 1.725

7.  COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency.

Authors:  Yan Beauverd; Yannick Adam; Benjamin Assouline; Kaveh Samii
Journal:  Eur J Haematol       Date:  2020-05-07       Impact factor: 2.997

8.  Mental health and quality of life for people with rheumatoid arthritis or ankylosing spondylitis in Aotearoa New Zealand following the COVID-19 national lockdown.

Authors:  Grace Johnstone; Gareth J Treharne; Benjamin D Fletcher; Roisin S M Lamar; Douglas White; Andrew Harrison; Simon Stebbings
Journal:  Rheumatol Int       Date:  2021-07-23       Impact factor: 2.631

9.  Science at Warp Speed: Medical Research, Publication, and Translation During the COVID-19 Pandemic.

Authors:  Wendy Lipworth; Melanie Gentgall; Ian Kerridge; Cameron Stewart
Journal:  J Bioeth Inq       Date:  2020-08-25       Impact factor: 1.352

Review 10.  Targeting zinc metalloenzymes in coronavirus disease 2019.

Authors:  Urszula Doboszewska; Piotr Wlaź; Gabriel Nowak; Katarzyna Młyniec
Journal:  Br J Pharmacol       Date:  2020-08-17       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.